These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16364641)

  • 21. Toward activated homology models of the human M1 muscarinic acetylcholine receptor.
    Chin SP; Buckle MJ; Chalmers DK; Yuriev E; Doughty SW
    J Mol Graph Model; 2014 Apr; 49():91-8. PubMed ID: 24631873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and dynamics of the full-length M1 muscarinic acetylcholine receptor studied by molecular dynamics simulations.
    Espinoza-Fonseca LM; Pedretti A; Vistoli G
    Arch Biochem Biophys; 2008 Jan; 469(1):142-50. PubMed ID: 17935687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
    Lanzafame AA; Sexton PM; Christopoulos A
    Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of partial agonists for the muscarinic m1 acetylcholine receptor.
    Chen X; Klöckner J; Holze J; Zimmermann C; Seemann WK; Schrage R; Bock A; Mohr K; Tränkle C; Holzgrabe U; Decker M
    J Med Chem; 2015 Jan; 58(2):560-76. PubMed ID: 25478907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the interaction of a putative allosteric modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), with M1 muscarinic acetylcholine receptors.
    Lanzafame A; Christopoulos A
    J Pharmacol Exp Ther; 2004 Mar; 308(3):830-7. PubMed ID: 14617684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration.
    Panarese JD; Cho HP; Adams JJ; Nance KD; Garcia-Barrantes PM; Chang S; Morrison RD; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3822-5. PubMed ID: 27173801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor.
    Marquer C; Fruchart-Gaillard C; Mourier G; Grandjean O; Girard E; le Maire M; Brown S; Servent D
    Biol Cell; 2010 Apr; 102(7):409-20. PubMed ID: 20170475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.
    Miller NR; Daniels RN; Bridges TM; Brady AE; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5443-7. PubMed ID: 18829311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: the role of water molecules examined.
    Hayes JM; Skamnaki VT; Archontis G; Lamprakis C; Sarrou J; Bischler N; Skaltsounis AL; Zographos SE; Oikonomakos NG
    Proteins; 2011 Mar; 79(3):703-19. PubMed ID: 21287607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7.
    Fruchart-Gaillard C; Mourier G; Marquer C; Ménez A; Servent D
    Mol Pharmacol; 2006 May; 69(5):1641-51. PubMed ID: 16439611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists.
    Liu B; Croy CH; Hitchcock SA; Allen JR; Rao Z; Evans D; Bures MG; McKinzie DL; Watt ML; Stuart Gregory G; Hansen MM; Hoogestraat PJ; Jamison JA; Okha-Mokube FM; Stratford RE; Turner W; Bymaster F; Felder CC
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4158-63. PubMed ID: 26299349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.
    Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM
    J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
    Langmead CJ; Fry VA; Forbes IT; Branch CL; Christopoulos A; Wood MD; Herdon HJ
    Mol Pharmacol; 2006 Jan; 69(1):236-46. PubMed ID: 16207821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonist binding in the rat muscarinic receptor A study by docking and X-ray crystallography.
    Tanczos AC; Palmer RA; Potter BS; Saldanha JW; Howlin BJ
    Comput Biol Chem; 2004 Dec; 28(5-6):375-85. PubMed ID: 15556478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
    Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
    Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical to Human Translational Pharmacology of the Novel M
    Uslaner JM; Kuduk SD; Wittmann M; Lange HS; Fox SV; Min C; Pajkovic N; Harris D; Cilissen C; Mahon C; Mostoller K; Warrington S; Beshore DC
    J Pharmacol Exp Ther; 2018 Jun; 365(3):556-566. PubMed ID: 29563325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
    Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.
    Ziegler N; Bätz J; Zabel U; Lohse MJ; Hoffmann C
    Bioorg Med Chem; 2011 Feb; 19(3):1048-54. PubMed ID: 20716489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.